New England Guild Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,568
Closed -$236K 74
2022
Q1
$236K Hold
4,568
0.13% 68
2021
Q4
$270K Buy
+4,568
New +$226K 0.14% 63

Other funds holding PFE

New England Guild Wealth Advisors's PFE Position: Q2 2022 in Review

New England Guild Wealth Advisors sold out of Pfizer (PFE) in Q2 2022, closing a stake of 4,568 shares — an estimated $236K sold.

New England Guild Wealth Advisors first reported a position in PFE in Q4 2021 and held it in 2 quarters. The position peaked at $270K in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • New England Guild Wealth Advisors reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • New England Guild Wealth Advisors sold 4,568 Pfizer shares in Q2 2022, an estimated $236K.
  • New England Guild Wealth Advisors first reported a position in Pfizer in Q4 2021 and held it in 2 quarters.
  • New England Guild Wealth Advisors's Pfizer position peaked at $270K in Q4 2021.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on New England Guild Wealth Advisors's 13F filing for Q2 2022, filed 8 Jul 2022.